JUNS

Conviction 57Scan · Mon, Aug 10, 2026

JUNS$5.30+3.92%

ResistanceSupportVol 14

Vol MA14 6.56M

May 11May 28Jun 16Jul 6Jul 23Aug 10

JUPITER NEUROSCIENCES, INC.PHARMACEUTICAL PREPARATIONSwww.jupiterneurosciences.com ↗

Price5.30

Change+3.92%

Gap+9.31%

Rel volume0.00×

Avg volume22.34M

Avg $ vol3.6M

SMA 200.6376

SMA 500.3937

SMA 2000.6640

Price vs 50+1246.14%

Price vs 200+698.25%

MA stackmixed

50/200 cross—

Supertrendup · 3.74

RSI (14)98

MACD hist0.52

MACD crossbull · 1d

Stoch %K / %D94 / 62

ADX (14)28

+DI / −DI88 / 1

RSI divergenceBullish

MACD divergenceBullish

ATR %+7.97%

ADR %16.24%

52w high5.30

52w low0.0751

From 52w high+0.00%

Above 52w low+6957.26%

New 52w highYes

SqueezeOff

Bollinger width954.57%

%B1.27

Donchian pos94.06%

Donchian high5.63

Donchian low0.0710

AVWAP (52w high)5.18

vs AVWAP high+2.22%

AVWAP (52w low)0.1584

vs AVWAP low+3245.00%

OBV trendUp

Chaikin MF (20)-0.50

Today vs 20d0.00×

Avg vol (14d)6.56M

Avg vol (20d)22.34M

Avg $ vol (20d)3.6M

Market cap—

RS 3m (vs SPY)+1376.86%

RS 6m (vs SPY)+714.21%

RS line new highYes

Trend template5/8

Technical rank99.6

1 week+5200.00%

1 month+2690.94%

3 months+1492.55%

6 months+784.22%

1 year+314.06%

YTD+424.75%

P/E-0.32

P/B-0.98

P/S125.01

P/FCF—

EPS-0.2500

Div yield—

ROE310.58%

ROA-218.94%

Debt/Eq—

Current0.51

EV/EBITDA—

Gross margin80.59%

Net margin—

Rev growth—

EPS growth-254.35%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.72M

Revenue18.65K

Net income-2.06M

Gross profit14.29K

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out36.28M

Employees5

ListedTue, Dec 3, 2024

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank99.6 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.2685

Support0.0771

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JUNS

All disclosures →

No recent disclosed trades by Congress in JUNS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JUNS · 5 buys · 5 sells

Insider	Side	Shares	Value	Traded	Filed
Cutler Andrew Jon Director · Stock Option (right to buy) · 2026-07-31	Grant	472.22K	—	2026-07-31	2026-08-05
Hayward Marshall A. Chief Scientific Officer · Common Stock · 2026-03-02	Exercise	225K	—	2026-03-02	2026-07-13
Hayward Marshall A. Chief Scientific Officer · Stock Option (right to buy) · 2026-03-02	Exercise	225K	—	2026-03-02	2026-07-13
Hayward Marshall A. Chief Scientific Officer · Restricted Stock Units · 2025-06-02	Exercise	389.79K	—	2025-06-02	2026-07-13
Hayward Marshall A. Chief Scientific Officer · Restricted Stock Award · 2025-06-02	Exercise	399.4K	—	2025-06-02	2026-07-13
Hemmerly Nicholas H. Director · Common Stock · 2025-06-02	Exercise	95.55K	—	2025-06-02	2026-07-13
Hemmerly Nicholas H. Director · Restricted Stock Units · 2025-06-02	Exercise	95.55K	—	2025-06-02	2026-07-13
Weis Holger Director · Common Stock · 2025-06-02	Exercise	85.8K	—	2025-06-02	2026-07-13
Weis Holger Director · Restricted Stock Units · 2025-06-02	Exercise	85.8K	—	2025-06-02	2026-07-13
Rosen Alexander Gustaf Erik Chief Administrative Officer · Common Stock · 2025-06-02	Exercise	164.55K	—	2025-06-02	2026-07-13

SEC filings

EDGAR filings in JUNS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.